GRAS Notices
-
GRN No. 960
Hypromellose acetate succinate
Intended Use: | Intended for use as an enteric coating agent, carrier for solid dispersions, and an enteric agent in tablets/caplets, granules, pellets, and capsules (including gel caps, pills, soft gels, and vegi caps) at levels ranging from 5% to 80% of the final product weight. |
---|---|
Basis: | Scientific procedures |
Notifier: | Shin-Etsu Chemical Co., Ltd. |
Notifier Address: |
YBP Technical Center, 134 Godo-cho Hodogaya-ku, Yokohama 240-0005 Japan |
GRAS Notice (releasable information): | GRN 960 with amendments (in PDF) (6.6 MB) |
Date of closure: | Dec 21, 2021 |
FDA's Letter: | FDA has no questions (126 kB) |
-